跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ROPIMATE TABLETS 100 mg - NPRA Drug Approval Details
Approvals
/
NPRA
/
ROPIMATE TABLETS 100 mg
Approved
STANDARD
ROPIMATE TABLETS 100 mg
RANBAXY (MALAYSIA) SDN. BHD.
🇲🇾 National Pharmaceutical Regulatory Agency
Approval Date
Nov 28, 2025
Approval ID
1756a20aa027c0a8
Company
RANBAXY (MALAYSIA) SDN. BHD.
Type
Standard
Approval Details
Approval Id
1756a20aa027c0a8
Drug Approval Npra Name
ROPIMATE TABLETS 100 mg
Product Name
ROPIMATE TABLETS 100 mg
Registration Number
MAL08082719ASZ
Holder Company Name
RANBAXY (MALAYSIA) SDN. BHD.
Holder Company Detail Path
/organization/ranbaxy-malaysia-sdn-bhd
Holder Address
LOT 23, BAKAR ARANG INDUSTRIAL ESTATE 08000 SUNGAI PETANI MALAYSIA
Holder Phone
04 4220660/04 4220661
Manufacturer Company Name
RANBAXY (MALAYSIA) SDN. BHD.
Manufacturer Company Detail Path
/organization/ranbaxy-malaysia-sdn-bhd
Manufacturer Address
LOT 23, BAKAR ARANG INDUSTRIAL ESTATE 08000 SUNGAI PETANI MALAYSIA
Source Url
https://quest3plus.bpfk.gov.my/pmo2/detail.php?type=product&id=MAL08082719ASZ
Version
1751614232
Active Ingredients
Approved
Quick Info
Agency
NPRA
Country
🇲🇾
Approval Date
Nov 28, 2025
Approval ID
1756a20aa027c0a8
Type
Standard
Source
Official Source
Back to NPRA Approvals